Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age.
Beder T, Hansen BT, Hartmann AM, Zimmermann J, Amelunxen E, Wolgast N, Walter W, Zaliova M, Antić Ž, Chouvarine P, Bartsch L, Barz MJ, Bultmann M, Horns J, Bendig S, Kässens J, Kaleta C, Cario G, Schrappe M, Neumann M, Gökbuget N, Bergmann AK, Trka J, Haferlach C, Brüggemann M, Baldus CD, Bastian L. Beder T, et al. Among authors: baldus cd. Hemasphere. 2023 Aug 25;7(9):e939. doi: 10.1097/HS9.0000000000000939. eCollection 2023 Sep. Hemasphere. 2023. PMID: 37645423 Free PMC article.
IGH Rearrangement Evolution in Adult KMT2A-rearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring.
Darzentas F, Szczepanowski M, Kotrová M, Kelm M, Hartmann A, Beder T, Gökbuget N, Neumann M, Bastian L, Baldus CD, Pál K, Darzentas N, Brüggemann M. Darzentas F, et al. Among authors: baldus cd. Hemasphere. 2022 Dec 20;7(1):e820. doi: 10.1097/HS9.0000000000000820. eCollection 2023 Jan. Hemasphere. 2022. PMID: 36570692 Free PMC article. No abstract available.
Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?
Kelm M, Darzentas F, Darzentas N, Kotrova M, Wessels W, Bendig S, Baldus CD, Lettau M, Gökbuget N, Kabelitz D, Brüggemann M, Chitadze G. Kelm M, et al. Among authors: baldus cd. Hemasphere. 2023 Sep 1;7(9):e948. doi: 10.1097/HS9.0000000000000948. eCollection 2023 Sep. Hemasphere. 2023. PMID: 37670805 Free PMC article. No abstract available.
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Kroeze E, Iaccarino I, Kleisman MM, Mondal M, Beder T, Khouja M, Höppner MP, Scheijde-Vermeulen MA, Kester LA, Brüggemann M, Baldus CD, Cario G, Bladergroen RS, Garnier N, Attarbaschi A, Verdu-Amorós J, Sutton R, Macintyre E, Scholten K, Arias Padilla L, Burkhardt B, Beishuizen A, den Boer ML, Kuiper RP, Loeffen JLC, Boer JM, Klapper W. Kroeze E, et al. Among authors: baldus cd. Blood. 2024 Jul 4;144(1):74-83. doi: 10.1182/blood.2024023938. Blood. 2024. PMID: 38588489
Advancing evolutionary medicine in Northern Germany: Collaboration between Kiel University's Medical Faculty and the Max Planck Institute for Evolutionary Biology.
Baines JF, Baldus CD, Bertels F, Brüggemann M, Kaleta C, Laudes M, Mueller FJ, Odenthal-Hesse L, Poyet M, Rainey PB, Rosenstiel P, Scheffold A, Sebens S, Thiery J, Traulsen A. Baines JF, et al. Among authors: baldus cd. Evol Med Public Health. 2024 Jul 24;12(1):117-121. doi: 10.1093/emph/eoae013. eCollection 2024. Evol Med Public Health. 2024. PMID: 39114444 Free PMC article. No abstract available.
Next-generation sequencing and high DNA input identify previously missed measurable residual disease in peripheral blood of B-cell precursor acute lymphoblastic leukaemia.
Bendig S, Bufe S, Kotrova M, Fricke B, Proske C, Darzentas F, Darzentas N, Schilhabel A, Kehden B, Chitadze G, Baldus CD, Gökbuget N, Brüggemann M. Bendig S, et al. Among authors: baldus cd. Br J Haematol. 2024 Oct 24. doi: 10.1111/bjh.19834. Online ahead of print. Br J Haematol. 2024. PMID: 39449173 No abstract available.
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukemia in children and young adults.
Feuchtinger T, Bader P, Subklewe M, Breidenbach M, Willier S, Metzler M, Gökbuget N, Hauer J, Müller F, Schlegel PG, Frühwald M, Schmid C, Troeger A, Baldus C, Meisel R, Künkele A, Topp M, Bourquin JP, Cario G, Von Stackelberg A, Peters C. Feuchtinger T, et al. Haematologica. 2024 Dec 1;109(12):3892-3903. doi: 10.3324/haematol.2023.283780. Haematologica. 2024. PMID: 38356450 Free PMC article. Review.
153 results